<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An 11-year-old boy with <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> sickle disease (<z:e sem="disease" ids="C0857813" disease_type="Disease or Syndrome" abbrv="">HbSD</z:e>), bilateral stenosis of the intracranial carotid arteries, and <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> had recurrent <z:hpo ids='HP_0002140'>ischemic strokes</z:hpo> with <z:hpo ids='HP_0002381'>aphasia</z:hpo> and right <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>His parents (Jehovah's Witnesses) refused blood transfusions </plain></SENT>
<SENT sid="2" pm="."><plain>After bilateral extracranial-intracranial (EC-IC) bypass surgery, <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> treatment <z:hpo ids='HP_0011904'>increased hemoglobin F</z:hpo> (HbF) levels to more than 30% </plain></SENT>
<SENT sid="3" pm="."><plain>During a follow-up of 28 months, flow velocities in the basal cerebral arteries remained stable, neurologic sequelae regressed, and ischemic events did not recur </plain></SENT>
<SENT sid="4" pm="."><plain>This is the first report of successful <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> treatment after bypass surgery for intracranial cerebral artery obstruction with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> in <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The patient's religious background contributed to an ethically challenging therapeutic task </plain></SENT>
<SENT sid="6" pm="."><plain>(Blood </plain></SENT>
<SENT sid="7" pm="."><plain>2001;97:2165-2167) </plain></SENT>
</text></document>